Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 140

1.

The pharmaco -, population and evolutionary dynamics of multi-drug therapy: experiments with S. aureus and E. coli and computer simulations.

Ankomah P, Johnson PJ, Levin BR.

PLoS Pathog. 2013;9(4):e1003300. doi: 10.1371/journal.ppat.1003300. Epub 2013 Apr 4.

PMID:
23593006
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

Two-drug antimicrobial chemotherapy: a mathematical model and experiments with Mycobacterium marinum.

Ankomah P, Levin BR.

PLoS Pathog. 2012 Jan;8(1):e1002487. doi: 10.1371/journal.ppat.1002487. Epub 2012 Jan 12.

PMID:
22253599
[PubMed - indexed for MEDLINE]
Free PMC Article
3.

Bactericidal effect of combinations of antibiotic and antineoplastic agents against Staphylococcus aureus and Escherichia coli.

Nyhlén A, Ljungberg B, Nilsson-Ehle I, Odenholt I.

Chemotherapy. 2002 May;48(2):71-7.

PMID:
12011538
[PubMed - indexed for MEDLINE]
4.

Effect of prophylactic antibiotics upon mixed infections with Bacteroides fragilis.

Brook I.

Surg Gynecol Obstet. 1987 Dec;165(6):491-5.

PMID:
3317944
[PubMed - indexed for MEDLINE]
5.

Staphylococcus aureus in continuous culture: a tool for the rational design of antibiotic treatment protocols.

Udekwu KI, Levin BR.

PLoS One. 2012;7(7):e38866. doi: 10.1371/journal.pone.0038866. Epub 2012 Jul 20.

PMID:
22911681
[PubMed - indexed for MEDLINE]
Free PMC Article
6.

In vitro and in vivo antibacterial activities of a novel glycylcycline, the 9-t-butylglycylamido derivative of minocycline (GAR-936).

Petersen PJ, Jacobus NV, Weiss WJ, Sum PE, Testa RT.

Antimicrob Agents Chemother. 1999 Apr;43(4):738-44.

PMID:
10103174
[PubMed - indexed for MEDLINE]
Free PMC Article
7.
8.

In vivo verification of in vitro model of antibiotic treatment of device-related infection.

Blaser J, Vergères P, Widmer AF, Zimmerli W.

Antimicrob Agents Chemother. 1995 May;39(5):1134-9.

PMID:
7625801
[PubMed - indexed for MEDLINE]
Free PMC Article
9.

Is there any rationale for treatment of Staphylococcus aureus infections with antimicrobials that are determined to be ineffective in vitro?

Uekötter A, Peters G, Becker K.

Clin Microbiol Infect. 2011 Aug;17(8):1142-7. doi: 10.1111/j.1469-0691.2011.03549.x. Epub 2011 Jun 14. Review.

PMID:
21672081
[PubMed - indexed for MEDLINE]
10.

Susceptibility to the main antibiotics of Escherichia coli and Staphylococcus aureus strains identified in community acquired infections in France (MedQual, 2004-2007).

Thibaut S, Caillon J, Huart C, Grandjean G, Lombrail P, Potel G, Ballereau F; Microbiology laboratories of the Pays de la Loire Region.

Med Mal Infect. 2010 Feb;40(2):74-80. doi: 10.1016/j.medmal.2009.01.011. Epub 2009 Oct 17.

PMID:
19837526
[PubMed - indexed for MEDLINE]
11.

Bacterial resistance to Quaternary Ammonium Compounds (QAC) disinfectants.

Bragg R, Jansen A, Coetzee M, van der Westhuizen W, Boucher C.

Adv Exp Med Biol. 2014;808:1-13. doi: 10.1007/978-81-322-1774-9_1.

PMID:
24595606
[PubMed - indexed for MEDLINE]
12.
13.

Antibiotic susceptibility patterns of community- and hospital-acquired Staphylococcus aureus and Escherichia coli in Estonia.

Karki T, Truusalu K, Vainumäe I, Mikelsaar M.

Scand J Infect Dis. 2001;33(5):333-8.

PMID:
11440217
[PubMed - indexed for MEDLINE]
14.

Escherichia coli and Staphylococcus aureus: bad news and good news from the European Antimicrobial Resistance Surveillance Network (EARS-Net, formerly EARSS), 2002 to 2009.

Gagliotti C, Balode A, Baquero F, Degener J, Grundmann H, Gür D, Jarlier V, Kahlmeter G, Monen J, Monnet DL, Rossolini GM, Suetens C, Weist K, Heuer O; EARS-Net Participants (Disease Specific Contact Points for AMR).

Euro Surveill. 2011 Mar 17;16(11). pii: 19819. Erratum in: Euro Surveill. 2011;16(14):pii/19834.

PMID:
21435327
[PubMed - indexed for MEDLINE]
Free Article
15.

A new method for normalized interpretation of antimicrobial resistance from disk test results for comparative purposes.

Kronvall G, Kahlmeter G, Myhre E, Galas MF.

Clin Microbiol Infect. 2003 Feb;9(2):120-32.

PMID:
12588332
[PubMed - indexed for MEDLINE]
16.

Prophylaxis with the immunomodulator PGG glucan enhances antibiotic efficacy in rats infected with antibiotic-resistant bacteria.

Tzianabos AO, Cisneros RL.

Ann N Y Acad Sci. 1996 Oct 25;797:285-7.

PMID:
8993382
[PubMed - indexed for MEDLINE]
17.

In vitro antibacterial activity of enrofloxacin and ciprofloxacin in combination against Escherichia coli and staphylococcal clinical isolates from dogs.

Lautzenhiser SJ, Fialkowski JP, Bjorling D, Rosin E.

Res Vet Sci. 2001 Jun;70(3):239-41.

PMID:
11676620
[PubMed - indexed for MEDLINE]
18.

[Quality control of antimicrobial susceptibility testing by disk diffusion test].

Ma Y, Li JY, Jin SH.

Zhonghua Yi Xue Za Zhi. 2003 Mar 10;83(5):355-6. Chinese. No abstract available.

PMID:
15558846
[PubMed - indexed for MEDLINE]
19.

Potential management of resistant microbial infections with a novel non-antibiotic: the anti-inflammatory drug diclofenac sodium.

Dutta NK, Annadurai S, Mazumdar K, Dastidar SG, Kristiansen JE, Molnar J, Martins M, Amaral L.

Int J Antimicrob Agents. 2007 Sep;30(3):242-9. Epub 2007 Jul 17.

PMID:
17644318
[PubMed - indexed for MEDLINE]
20.
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk